Volume 5 Issue 3 - International Pharmaceutical Industry

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Clinical Research

Cardiovascular Therapeutics Watch Column

Rick Turner at Quintiles provides an overview of how one of the hottest areas in the treatment of hypertension concerns drug-resistant hypertension. Drug-resistant h...

17 October 2013 Clinical Research | Editorial Archive | Volume 5 Issue 3

Continue Reading →

Editorial Archive

Innovative Injectable Drug Delivery Systems

Innovative and complex ideas in the field of polymer injectable drug delivery systems need a capable partner to succeed in realisation. Customised products such as n...

17 October 2013 Editorial Archive | Volume 5 Issue 3

Continue Reading →

Editorial Archive

Disruptive Change by Linked Data and Semantic Technologies in Healthcare and Life Sciences

The pharmaceutical industry is undergoing an enormous shift in structure and strategy to reinvent how to bring new drugs to market efficiently. Hans Constandt at Ont...

17 October 2013 Editorial Archive | Volume 5 Issue 3

Continue Reading →

Editorial Archive

Engineering Enhancements in Drug Delivery

The accelerating pace of technological development is offering new possibilities for manufacturers across the industry, and the need for all sectors to share both kn...

17 October 2013 Editorial Archive | Volume 5 Issue 3

Continue Reading →

Editorial Archive

Engineering Enhancements in Drug Delivery

The accelerating pace of technological development is offering new possibilities for manufacturers across the industry, and the need for all sectors to share both kn...

16 October 2013 Editorial Archive | Volume 5 Issue 3

Continue Reading →

Editorial Archive

Biocatalysis is a Key Technology for Successful Chiral Synthesis

It is now well-recognised that the need for green, economic, robust and scaleable processes is at the forefront of customer research plans for the synthesis of chira...

16 October 2013 Editorial Archive | Volume 5 Issue 3

Continue Reading →

Editorial Archive

Partnering to Drive Innovation – A Supercritical Success Story

Paul Titley at Aesica Pharmaceuticals and Peter York at Crystec Pharma, discuss the design, development and manufacture of modern medicines pose numerous scientific ...

16 October 2013 Editorial Archive | Regulatory & Marketplace V5 I3 | Volume 5 Issue 3

Continue Reading →

Editorial Archive

Supplementary Protection for Medicines – Functioning or Failing?

The legislation governing Supplementary Protection Certificates for medicinal products, EU Regulation No. 469/2009 ‘the Regulation’, scores well on brevity but it fa...

16 October 2013 Editorial Archive | Regulatory & Marketplace V5 I3 | Volume 5 Issue 3

Continue Reading →

Editorial Archive

Compounding Success: Patenting Known Molecules in Europe and the UK

Once an inventor has identified a candidate pharmaceutical molecule, the prime objective should be to secure patent protection for the molecule itself together with ...

16 October 2013 Editorial Archive | Regulatory & Marketplace V5 I3 | Volume 5 Issue 3

Continue Reading →

Editorial Archive

Life Science Austria: Advancing Life Science at the Heart of Europe

Over the past decade, Austria has established itself as a well-respected hub of the life science industry. Region by region, the life science industry has spread acr...

16 October 2013 Editorial Archive | Regulatory & Marketplace V5 I3 | Volume 5 Issue 3

Continue Reading →